321 related articles for article (PubMed ID: 9065469)
1. Inhibitory mechanism of the protein C pathway on tissue factor-induced thrombin generation. Synergistic effect in combination with tissue factor pathway inhibitor.
van 't Veer C; Golden NJ; Kalafatis M; Mann KG
J Biol Chem; 1997 Mar; 272(12):7983-94. PubMed ID: 9065469
[TBL] [Abstract][Full Text] [Related]
2. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II.
van 't Veer C; Mann KG
J Biol Chem; 1997 Feb; 272(7):4367-77. PubMed ID: 9020158
[TBL] [Abstract][Full Text] [Related]
3. Increased tissue factor-initiated prothrombin activation as a result of the Arg506 --> Gln mutation in factor VLEIDEN.
van 't Veer C; Kalafatis M; Bertina RM; Simioni P; Mann KG
J Biol Chem; 1997 Aug; 272(33):20721-9. PubMed ID: 9252393
[TBL] [Abstract][Full Text] [Related]
4. Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor.
van 't Veer C; Hackeng TM; Delahaye C; Sixma JJ; Bouma BN
Blood; 1994 Aug; 84(4):1132-42. PubMed ID: 8049429
[TBL] [Abstract][Full Text] [Related]
5. "Normal" thrombin generation.
Butenas S; van't Veer C; Mann KG
Blood; 1999 Oct; 94(7):2169-78. PubMed ID: 10498586
[TBL] [Abstract][Full Text] [Related]
6. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation.
Hoffman M; Monroe DM; Oliver JA; Roberts HR
Blood; 1995 Sep; 86(5):1794-801. PubMed ID: 7655009
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases.
Butenas S; van 't Veer C; Mann KG
J Biol Chem; 1997 Aug; 272(34):21527-33. PubMed ID: 9261172
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa.
van 't Veer C; Golden NJ; Mann KG
Blood; 2000 Feb; 95(4):1330-5. PubMed ID: 10666207
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.
Pedersen AH; Nordfang O; Norris F; Wiberg FC; Christensen PM; Moeller KB; Meidahl-Pedersen J; Beck TC; Norris K; Hedner U
J Biol Chem; 1990 Oct; 265(28):16786-93. PubMed ID: 2211593
[TBL] [Abstract][Full Text] [Related]
10. An in vitro analysis of the combination of hemophilia A and factor V(LEIDEN).
van 't Veer C; Golden NJ; Kalafatis M; Simioni P; Bertina RM; Mann KG
Blood; 1997 Oct; 90(8):3067-72. PubMed ID: 9376587
[TBL] [Abstract][Full Text] [Related]
11. Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase.
Mast AE; Broze GJ
Blood; 1996 Mar; 87(5):1845-50. PubMed ID: 8634431
[TBL] [Abstract][Full Text] [Related]
12. A model for the tissue factor pathway to thrombin. I. An empirical study.
Lawson JH; Kalafatis M; Stram S; Mann KG
J Biol Chem; 1994 Sep; 269(37):23357-66. PubMed ID: 8083241
[TBL] [Abstract][Full Text] [Related]
13. Factor VIIa/tissue factor generates a form of factor V with unchanged specific activity, resistance to activation by thrombin, and increased sensitivity to activated protein C.
Safa O; Morrissey JH; Esmon CT; Esmon NL
Biochemistry; 1999 Feb; 38(6):1829-37. PubMed ID: 10026263
[TBL] [Abstract][Full Text] [Related]
14. Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulation.
Koshiar RL; Somajo S; Norström E; Dahlbäck B
PLoS One; 2014; 9(8):e104200. PubMed ID: 25136857
[TBL] [Abstract][Full Text] [Related]
15. The regulation of the factor VII-dependent coagulation pathway: rationale for the effectiveness of recombinant factor VIIa in refractory bleeding disorders.
van't Veer C; Mann KG
Semin Thromb Hemost; 2000; 26(4):367-72. PubMed ID: 11092210
[TBL] [Abstract][Full Text] [Related]
16. Phospholipid-bound tissue factor modulates both thrombin generation and APC-mediated factor Va inactivation.
Váradi K; Siekmann J; Turecek PL; Schwarz HP; Marder VJ
Thromb Haemost; 1999 Dec; 82(6):1673-9. PubMed ID: 10613654
[TBL] [Abstract][Full Text] [Related]
17. The regulation of clotting factors.
Kalafatis M; Egan JO; van 't Veer C; Cawthern KM; Mann KG
Crit Rev Eukaryot Gene Expr; 1997; 7(3):241-80. PubMed ID: 9399073
[TBL] [Abstract][Full Text] [Related]
18. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
Ofosu FA; Lormeau JC; Craven S; Dewar L; Anvari N
Thromb Haemost; 1994 Dec; 72(6):862-8. PubMed ID: 7740455
[TBL] [Abstract][Full Text] [Related]
19. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor.
Rao LV; Ruf W
Biochemistry; 1995 Aug; 34(34):10867-71. PubMed ID: 7662667
[TBL] [Abstract][Full Text] [Related]
20. A new regulatory function of activated factor V: inhibition of the activation by tissue factor/factor VII(a) of factor X.
Al Dieri R; Bloemen S; Kelchtermans H; Wagenvoord R; Hemker HC
J Thromb Haemost; 2013 Mar; 11(3):503-11. PubMed ID: 23294934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
